Sarasota Retina Institute

Sarasota, Florida 34239-7246

3 studies enrolling now · 43 studies all time

What they study most

Age Related Macular Degeneration, Age-Related Macular Degeneration, Age-related Macular Degeneration, Anterior Ischemic Optic Neuropathy, Blepharoptosis, Cataract, Central Retinal Vein Occlusion, Diabetic Macular Edema, Diabetic Retinopathy, Dry Eye Syndromes, Endocrine System Diseases, Epiretinal Membrane

Studies at this site

• Randomized Trial Comparing Immediate vs. Deferred Surgery for Symptomatic ERM — Recruiting now
• A Study of AMG 732 in Healthy Participants and Participants With Thyroid Eye Disease — Recruiting now
• Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD — Recruiting now
• Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD — Running, not enrolling
• Fenofibrate for Prevention of DR Worsening — Running, not enrolling
• A Safety and Tolerability Study of VRDN-003 in Participants With Thyroid Eye Disease (TED) — Running, not enrolling
• An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Chronic Thyroid Eye Disease (TED) — Running, not enrolling
• An Open-label Study (OLE) for Non-responders of VRDN-001-101 (NCT05176639) and VRDN-001-301 (NCT06021054) — Completed
• A Randomized, Controlled, Safety and Tolerability Study of VRDN-001 in Participants With Thyroid Eye Disease (TED) — Completed
• An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Active Thyroid Eye Disease (TED) — Running, not enrolling
• An Efficacy, Safety, and Tolerability Study of Veligrotug (VRDN-001), in Participants With Chronic Thyroid Eye Disease (TED) (THRIVE-2) — Completed
• A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED) — Running, not enrolling
• DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME — Completed
• A Phase 2 Study to Assess the Safety and Efficacy of Intravitreal ONL1204 Ophthalmic Solution in Subjects With Mac-off Retinal Detachment — Completed
• Comparing the Efficacy and Safety of Biosimilar Candidate Xlucane Versus Lucentis® in Patients With nAMD — Completed
• Anti-VEGF Treatment for Prevention of PDR/DME — Completed
• Effects of Pneumatic Vitreolysis on Vitreomacular Traction — Completed
• Effects of Pneumatic Vitreolysis on Macular Hole — Completed
• Safety and Tolerability Study of UBX1325 in Patients With Diabetic Macular Edema or Neovascular Age-Related Macular Degeneration — Completed
• Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) — Completed
• Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema — Completed
• Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO — Stopped early
• Study of Safety and Efficacy of RVL-1201 in the Treatment of Blepharoptosis — Completed
• PROMINENT-Eye Ancillary Study (Protocol AD) — Stopped early
• Study of Safety of RVL-1201 in Treatment of Blepharoptosis — Completed
• Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema — Completed
• Treatment for CI-DME in Eyes With Very Good VA Study — Completed
• Safety and Efficacy of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration — Completed
• Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) — Stopped early
• Evaluation of Vitrectomy for Diabetic Macular Edema — Completed
• HOme Vision Monitoring in AREDS2 for Progression to Neovascular AMD Using the ForeseeHome Device — Completed
• Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye — Stopped early
• PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) — Stopped early
• Phase II Combination Steroid and Anti-VEGF for Persistent DME — Completed
• Telescope Exchange Study — Status unconfirmed
• A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors — Completed
• Intravitreal Triamcinolone Acetonide Versus Laser for Diabetic Macular Edema — Completed
• Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N) — Completed
• Ocriplasmin Research to Better Inform Treatment (ORBIT) — Completed
• Age-Related Eye Disease Study 2 (AREDS2) — Completed
• Trial of Microplasmin Intravitreal Injection for Non-surgical Treatment of Focal Vitreomacular Adhesion. The MIVI-TRUST (TG-MV-006) Trial. — Completed
• Safety Study of a Single IVT Injection of QPI-1007 in Chronic Optic Nerve Atrophy and Recent Onset NAION Patients — Completed
• Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage — Completed